Intrapartum Magnesium for Neuroprotection: Revisiting Gestational Age Criteria
- PMID: 37581684
- DOI: 10.1001/jama.2023.10673
Intrapartum Magnesium for Neuroprotection: Revisiting Gestational Age Criteria
Comment on
-
Prenatal Intravenous Magnesium at 30-34 Weeks' Gestation and Neurodevelopmental Outcomes in Offspring: The MAGENTA Randomized Clinical Trial.JAMA. 2023 Aug 15;330(7):603-614. doi: 10.1001/jama.2023.12357. JAMA. 2023. PMID: 37581672 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
